Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-07-22
1994-02-01
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483361, A61K 31415, C07D23360
Patent
active
052832546
ABSTRACT:
The present invention relates to 2-(imidazol-1-yl)-2 -benzylethylidene-aminoxyalkanoic acid derivatives of formula (I) ##STR1## wherein A is a divalent group of formula ##STR2## in which R is hydrogen, halogen, CF.sub.3, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylsulfonyl or cyano;
REFERENCES:
Derwent Abstract of WO 91/13062, Farmitalia Carlo Erba, published Sep. 5, 1991.
Derwent Abstract of DE 3334220, Bayer AG, published on Nov. 4, 1985.
Cover page and Derwent Abstract of EP 0,028,346, Bayer AG, published on May 20, 1981.
Cover Page and Derwent Abstract of European, 0,065,107, Bayer AG, published on Nov. 24, 1988.
Derwent Abstract of EP 0132771, Hoechst AG, published on Feb. 13, 1985.
Derwent Abstract of DE 3548085, Bayer AG, published on Jul. 2, 1987.
Derwent Abstract of EP 0158299, Merz & Co., published on Oct. 16, 1985.
Cozzi Paolo
Ferti Corrado
Menichincheri Maria
Rossi Arsenia
Salvati Patricia
Farmitalia Carlo Erba S.r.l.
Morris Patricia L.
LandOfFree
2-(imidazol-1-yl)-2-benzylethyldiene-aminoxyalkanoic acid deriva does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(imidazol-1-yl)-2-benzylethyldiene-aminoxyalkanoic acid deriva, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(imidazol-1-yl)-2-benzylethyldiene-aminoxyalkanoic acid deriva will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-580046